Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | OMTX705 |
| Trade Name | |
| Synonyms | OMTX 705|OMTX-705 |
| Drug Descriptions |
OMTX705 is an antibody-drug conjugate that targets fibroblast-activating protein alpha (FAP-alpha), potentially resulting in increased killing of tumor cells, T cell infiltration, and inhibition of tumor growth (PMID: 32161121). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Gemcitabine + OMTX705 | Gemcitabine OMTX705 | 0 | 0 |
| OMTX705 | OMTX705 | 0 | 1 |
| OMTX705 + Paclitaxel | OMTX705 Paclitaxel | 0 | 0 |
| OMTX705 + Pembrolizumab | OMTX705 Pembrolizumab | 0 | 1 |
| OMTX705 + Tislelizumab | OMTX705 Tislelizumab | 0 | 1 |